Abstract:Motivation: The use of drug combinations, termed polypharmacy, is common to treat patients with complex diseases or co-existing conditions. However, a major consequence of polypharmacy is a much higher risk of adverse side effects for the patient. Polypharmacy side effects emerge because of drug-drug interactions, in which activity of one drug may change, favorably or unfavorably, if taken with another drug. The knowledge of drug interactions is often limited because these complex relationships are rare, and are usually not observed in relatively small clinical testing. Discovering polypharmacy side effects thus remains an important challenge with significant implications for patient mortality and morbidity.Results: Here, we present Decagon, an approach for modeling polypharmacy side effects. The approach constructs a multimodal graph of protein-protein interactions, drug-protein target interactions and the polypharmacy side effects, which are represented as drug-drug interactions, where each side effect is an edge of a different type. Decagon is developed specifically to handle such multimodal graphs with a large number of edge types. Our approach develops a new graph convolutional neural network for multirelational link prediction in multimodal networks. Unlike approaches limited to predicting simple drug-drug interaction values, Decagon can predict the exact side effect, if any, through which a given drug combination manifests clinically. Decagon accurately predicts polypharmacy side effects, outperforming baselines by up to 69%. We find that it automatically learns representations of side effects indicative of co-occurrence of polypharmacy in patients. Furthermore, Decagon models particularly well polypharmacy side effects that have a strong molecular basis, while on predominantly non-molecular side effects, it achieves good performance because of effective sharing of model parameters across edge types. Decagon opens up opportunities to use large pharmacogenomic and patient population data to flag and prioritize polypharmacy side effects for follow-up analysis via formal pharmacological studies.Availability and implementation: Source code and preprocessed datasets are at: http://snap.stanford.edu/decagon.

DeepPSE: Prediction of polypharmacy side effects by fusing deep representation of drug pairs and attention mechanism

Polypharmacy side effect prediction based on semi-implicit graph variational auto-encoder

Effective knowledge graph embeddings based on multidirectional semantics relations for polypharmacy side effects prediction

ADEP: A Novel Approach Based on Discriminator-Enhanced Encoder-Decoder Architecture for Accurate Prediction of Adverse Effects in Polypharmacy

MSDSE: Predicting drug-side effects based on multi-scale features and deep multi-structure neural network

Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.

Drug Side Effect Prediction Through Linear Neighborhoods and Multiple Data Source Integration

DSEP: A Tool Implementing Novel Method to Predict Side Effects of Drugs.

PU‐GNN: A Positive‐Unlabeled Learning Method for Polypharmacy Side‐Effects Detection Based on Graph Neural Networks

Drug Side-effect Prediction Based on Comprehensive Drug Similarity

Large-scale Exploration and Analysis of Drug Combinations

Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge

BACON: Boundary-guided Polypharmacy Side Effect Prediction via Integrating Molecular Structures and Biochemical Information.

Fast Polypharmacy Side Effect Prediction Using Tensor Factorisation

Polypharmacy side-effect prediction with enhanced interpretability based on graph feature attention network

Drug-Drug Adverse Effect Prediction with Graph Co-Attention

A Unified View of Relational Deep Learning for Drug Pair Scoring

Deep learning for predicting synergistic drug combinations: State‐of‐the‐arts and future directions

Learning Multi-Types of Neighbor Node Attributes and Semantics by Heterogeneous Graph Transformer and Multi-View Attention for Drug-Related Side-Effect Prediction

Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning

Modeling polypharmacy side effects with graph convolutional networks